MW 750.7 Da, Purity >99%. Potent, selective D2-like dopamine receptor agonist (Ki values are ~8 (D2), ~5 (D3), ~290 (D4), ~440 (D1) and ~450 nM (D5)). Inhibits the release of pituitary prolactin and stimulates motor activity in Parkinson's disease. Also reverses glutamate transporter 1 (GLT-1) activity, increasing glutamate levels.
22260-51-1
> 99%
Solid
750.7 Da
C33H44BrN5O8S
31100
Synthetic
ACEE, ACES_HUMAN, ACLS, AIS, ANDR_HUMAN, AR, AR8, ARACHE, Acetylcholinesterase, Androgen nuclear receptor variant 2, Androgen receptor, Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease), Apoptosis related acetylcholinesterase, Atherosclerosis, susceptibility to, included, DHTR, DKFZp686N23123, DNA binding protein, Dihydro testosterone receptor, Dihydrotestosterone receptor (DHTR), ER, ER-alpha, ER-beta, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, ESTR B, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen-related receptor alpha, Estrra, GCPS, GLI Kruppel family member GLI 3, GLI Kruppel family member GLI3 (Greig cephalopolysyndactyly syndrome), GLI family zinc finger 3, GLI3 C-terminally truncated form, GLI3 form of 190 kDa, GLI3 form of 83 kDa, GLI3 full length protein, GLI3-190, GLI3-83, GLI3FL, GLI3_HUMAN, Glioma associated oncogene family zinc finger 3, HDL cholesterol, augmented response of, to hormone replacement, included, HUMARA, HYSP1, IMD42, KD, Kennedy disease (KD), MGC129539, Myocardial infarction, susceptibility to, included, N-ACHE, NF-E2-related factor 2, NF2L2_HUMAN, NR1F3, NR3A1, NR3A2, NR3B1, NR3C4, NRF2, Nfe2l2, Nuclear factor, Nuclear factor (erythroid derived 2) like 2, Nuclear factor erythroid 2-related factor 2, Nuclear factor erythroid derived 2 like 2, Nuclear receptor ROR-gamma, Nuclear receptor RZR-gamma, Nuclear receptor subfamily 1 group F member 3, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 4, Nuclear receptor subfamily 3 group C member 4 (NR3C4), OTTHUMP00000017718, OTTHUMP00000017719, Oncogene GLI3, PAP A, PAPB, PPD IV, RAR related orphan nuclear receptor variant 2, RAR related orphan receptor C, isoform a, RAR related orphan receptor gamma, RAR-related orphan receptor C, RNESTROR, RORG_HUMAN, RZR GAMMA, RZRG, Retinoic acid binding receptor gamma, Retinoid-related orphan receptor-gamma, Rorc, SBMA, SMAX1, Spinal and bulbar muscular atrophy, Spinal and bulbar muscular atrophy (SBMA), Steroid hormone receptor ERR1, TFM, TOR, Testicular Feminization (TFM), Transcriptional activator GLI3, Transcriptional repressor GLI3R, YT, YT blood group, Zinc finger protein GLI 3, androgen receptor splice variant 4b, erythroid derived 2, estrogen receptor related receptor alpha, hERR1, like 2, nuclear factor erythroid 2 like 2
MW 750.7 Da, Purity >99%. Potent, selective D2-like dopamine receptor agonist (Ki values are ~8 (D2), ~5 (D3), ~290 (D4), ~440 (D1) and ~450 nM (D5)). Inhibits the release of pituitary prolactin and stimulates motor activity in Parkinson's disease. Also reverses glutamate transporter 1 (GLT-1) activity, increasing glutamate levels.
22260-51-1
> 99%
Solid
750.7 Da
C33H44BrN5O8S
31100
Synthetic
Soluble in DMSO to 100 mM. Soluble in ethanol to 25 mM (with heating).
Bromocriptine mesylate
Potent, selective D2-like dopamine receptor agonist (Ki values are ~8 (D2), ~5 (D3), ~290 (D4), ~440 (D1) and ~450 nM (D5)). Inhibits the release of pituitary prolactin and stimulates motor activity in Parkinson's disease. Also reverses glutamate transporter 1 (GLT-1) activity, increasing glutamate levels.
CC(C)CC1C(=O)N2CCCC2C3(N1C(=O)C(O3)(C(C)C)NC(=O)C4CN(C5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O
CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C(C)C)NC(=O)[C@H]4CN([C@@H]5CC6=C(NC7=CC=CC(=C67)C5=C4)Br)C)O.CS(=O)(=O)O
InChI=1S/C32H40BrN5O5.CH4O3S/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18;1-5(2,3)4/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39);1H3,(H,2,3,4)/t18-,23-,24+,25+,31-,32+;/m1./s1
NOJMTMIRQRDZMT-GSPXQYRGSA-N
(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
Ambient - Can Ship with Ice
+4°C
+4°C
The product can be stored for up to 12 months
This supplementary information is collated from multiple sources and compiled automatically.
Estrogen Receptor (ER) functions as a nuclear receptor and transcription factor activated by the hormone estrogen. Also called NR3A1 its molecular mass is approximately 66 kDa. ER is highly expressed in breast and reproductive tissues as well as in diverse areas of the brain. Acetylcholinesterase (AChE) catalyzes the breakdown of acetylcholine into choline and acetate critical for neurotransmission. AChE is prominently found in neuromuscular junctions and cholinergic brain synapses. Gli3 a transcription factor and member of the Gli family modulates gene expression in response to Hedgehog signaling. Predominantly expressed in development-related tissues it has a role in limb and central nervous system formation. Androgen Receptor (AR) with a mass around 110 kDa acts similarly to ER but responds to androgens and is expressed in tissues like prostate and skin. Estrogen Related Receptor alpha (ERRα) is a nuclear receptor often expressed in energy-demanding tissues. ROR gamma (RORγ) related to immune and metabolic processes activates transcriptional programs. Lastly Nrf2 regulates antioxidant response and is most active in liver and lung tissues.
ER regulates gene expression essential for reproductive and breast tissue development. Like many nuclear receptors it forms a complex with coactivators and DNA to initiate transcription. AChE's role extends beyond neurotransmission influencing processes like cell growth and stress responses. Gli3 partakes in developmental pattern formation by acting as both an activator and repressor depending on the cellular context. AR similarly regulates target genes important for male sexual development and other functions. ERRα contributes to mitochondrial biogenesis and energy metabolism often acting independently and with co-regulators. RORγ influences immune regulation especially in lymph nodes and thymus. Nrf2 while not part of a specific complex activates various detoxifying enzymes to protect cells from oxidative damage.
ER is critical in the estrogen signaling pathway influencing cellular proliferation and apoptosis and interacts with proteins like coactivator p300. AChE plays a role in synaptic transmission within the cholinergic pathway where it interacts with proteins such as nicotinic acetylcholine receptors. Gli3 operates in the Hedgehog signaling pathway interacting with Smoothened and Patched proteins important for developmental processes. AR is part of the androgen signaling pathway connected with proteins like FKBP5 impacting cellular growth. ERRα links with the AMPK pathway modulating cellular energy levels. RORγ integrates into the Th17 differentiation pathway aiding immune responses. Nrf2 is key in the oxidative stress response pathway interfacing with KEAP1 and ARE sequences to regulate antioxidant proteins.
ER associations are prominent in breast cancer where it interacts with proteins like HER2 and contributes to tumor progression. AChE is linked to Alzheimer's disease due to its involvement in cholinergic system dysfunction. Gli3 mutations can lead to Greig cephalopolysyndactyly syndrome affecting development. Dysregulation of AR is central in prostate cancer with ties to proteins like PSA promoting cancer cell survival. ERRα though not closely tied to specific diseases influences metabolic disorders through its regulatory functions. RORγ's role in autoimmune diseases like rheumatoid arthritis involves interaction with cytokines IL-17. Lastly Nrf2 is associated with chronic obstructive pulmonary disease (COPD) where it interacts with inflammatory pathways highlighting its role in maintaining oxidative balance.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
2D chemical structure image of ab120574, Bromocriptine mesylate, D2-like dopamine receptor agonist
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com